137 related articles for article (PubMed ID: 19062042)
1. Increased survival from stage IV melanoma associated with fewer regulatory T Cells.
Baumgartner JM; Gonzalez R; Lewis KD; Robinson WA; Richter DA; Palmer BE; Wilson CC; McCarter MD
J Surg Res; 2009 Jun; 154(1):13-20. PubMed ID: 19062042
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
3. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.
López MN; Pereda C; Segal G; Muñoz L; Aguilera R; González FE; Escobar A; Ginesta A; Reyes D; González R; Mendoza-Naranjo A; Larrondo M; Compán A; Ferrada C; Salazar-Onfray F
J Clin Oncol; 2009 Feb; 27(6):945-52. PubMed ID: 19139436
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.
Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426
[TBL] [Abstract][Full Text] [Related]
5. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma.
Gray CP; Arosio P; Hersey P
Clin Cancer Res; 2003 Jul; 9(7):2551-9. PubMed ID: 12855630
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
[TBL] [Abstract][Full Text] [Related]
7. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
[TBL] [Abstract][Full Text] [Related]
8. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.
Westendorf AM; Fleissner D; Groebe L; Jung S; Gruber AD; Hansen W; Buer J
Gut; 2009 Feb; 58(2):211-9. PubMed ID: 18832523
[TBL] [Abstract][Full Text] [Related]
9. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
Dolganiuc A; Paek E; Kodys K; Thomas J; Szabo G
Gastroenterology; 2008 Dec; 135(6):2119-27. PubMed ID: 18835391
[TBL] [Abstract][Full Text] [Related]
10. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
Abediankenari S; Ghasemi M
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma].
Cai XY; Qiu SJ; Wu ZQ; Ye SL; Fan J; Zhou J; Tang ZY
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):671-5. PubMed ID: 15932729
[TBL] [Abstract][Full Text] [Related]
12. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells.
Dumitriu IE; Dunbar DR; Howie SE; Sethi T; Gregory CD
J Immunol; 2009 Mar; 182(5):2795-807. PubMed ID: 19234174
[TBL] [Abstract][Full Text] [Related]
13. Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
Chen LL; Ye F; Yu Y; Chen HZ; Zhang WW; Lü WG; Xie X
Gynecol Oncol; 2009 Jan; 112(1):199-204. PubMed ID: 19022493
[TBL] [Abstract][Full Text] [Related]
14. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
[TBL] [Abstract][Full Text] [Related]
15. A novel method for isolating dendritic cells from human bronchoalveolar lavage fluid.
Ten Berge B; Muskens F; Kleinjan A; Hammad H; Hoogsteden HC; Lambrecht BN; Van den Blink B
J Immunol Methods; 2009 Dec; 351(1-2):13-23. PubMed ID: 19804781
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S
J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789
[TBL] [Abstract][Full Text] [Related]
17. Presence and maturity of dendritic cells in melanoma lymph node metastases.
Polak ME; Johnson P; Di Palma S; Higgins B; Hurren J; Borthwick NJ; Jager MJ; Mccormick D; Cree IA
J Pathol; 2005 Sep; 207(1):83-90. PubMed ID: 15983979
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
Ye Z; Wang Y; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
[TBL] [Abstract][Full Text] [Related]
19. The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population.
Narbutt J; Lesiak A; Zak-Prelich M; Woźniacka A; Sysa-Jedrzejowska A; Tybura M; Robak T; Smolewski P
Cell Mol Biol Lett; 2004; 9(3):497-509. PubMed ID: 15332126
[TBL] [Abstract][Full Text] [Related]
20. [Alteration and biological significance of peripheral dendritic cells in patients with chronic idiopathic thrombocytopenic purpura].
Ling Y; Cao XS; Yu ZQ; Qiu GQ; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):187-91. PubMed ID: 18788620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]